Delivery of fluid during transurethral prostate treatment

• US 20040215181A1
• Filed: 04/25/2003
• Published: 10/28/2004
• Est. Priority Date: 04/25/2003
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Skwarek, Thomas Richard, Christopherson, Mark A.
• Application Number:
  US10/424,040
• Publication Number:
  US 20040215181A1
• Time in Patent Office: Days
• US Class Current: 606/32
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2017/00274 Prostate operation, e.g. prostatectomy, turp, bhp treatment
• CPC Class Codes: A61B 2018/00547 Prostate
• CPC Class Codes: A61B 2018/143 multiple needles
• CPC Class Codes: A61B 2018/1472 for use with liquid electrolyte, e.g. virtual electrodes
• CPC Class Codes: A61B 2218/002 Irrigation
• CPC Class Codes: A61P 13/08 of the prostate

Abstract

In general, the invention provides a transurethral ablation device comprising a fluid delivery port for delivery of a fluid, such as a gel, liquid, or liquid suspension, to a tissue site targeted for ablation. The fluid is electrically conductive and carries a local anesthetic agent. When the fluid is delivered, it provides an anesthetic effect in the target tissue site, alleviating pain associated with the ablation procedure. In addition, the fluid is loaded with electrically conductive material to enhance conductivity and permit the creation of a virtual electrode. The virtual electrode extends throughout the volume of fluid delivered to the target tissue site, and enhances the volumetric coverage and precision of the ablation procedure with the prostate tissue.

Claims

1. A method comprising:

delivering an electrically conductive fluid containing an anesthetic agent to a prostate of a male patient; and

delivering ablation energy to the prostate.

2. The method of claim 1, further comprising:

inserting a catheter into a urethra of the patient; and

delivering the fluid via an ablation needle carried by the catheter.

3. The method of claim 1, further comprising delivering the fluid via a catheter.

4. The method of claim 1, further comprising delivering the fluid before the delivery of the ablation energy.

5. The method of claim 1, further comprising delivering the fluid during the delivery of the ablation energy.

6. The method of claim 1, further comprising stopping delivery of the ablation energy, and delivering the fluid after stopping delivery of the ablation energy.

7. The method of claim 1, wherein the ablation energy includes electrical current selected to kill cells within the prostate.

8. The method of claim 1, wherein the fluid includes a gel-based material loaded with the anesthetic agent and conductive material.

9. The method of claim 8, wherein the anesthetic agent includes at least one of benzocaine, dyclonine, markaine, sensorcaine, lidocaine, and lidocaine hydrochloride.

10. The method of claim 1, further comprising penetrating a wall of a urethra of the patient with an ablation needle, extending the ablation needle into the prostate, delivering the fluid to the prostate via the ablation needle, and delivering the ablation energy to the prostate via the ablation needle.

11. The method of claim 1, further comprising delivering the fluid to a wall of the urethra of the patient.

12. The method of claim 1, further comprising delivering the fluid via a fluid deliver port in a catheter.

13. The method of claim 1, further comprising delivering the fluid and the ablation energy via a transurethral catheter.

14. The method of claim 1, wherein the fluid is a gel.

15. The method of claim 1, wherein the fluid includes a steroid.

16. The method of claim 1, wherein the fluid includes a vaso-constrictor.

17. A transurethral ablation system comprising:

a transurethral catheter;

an ablation needle extendable from the catheter to penetrate a prostate of a patient;

a fluid delivery conduit extending within the catheter;

an ablation energy generator to deliver ablation energy to the prostate via the ablation probe; and

a fluid delivery device to deliver fluid to the prostate via the fluid delivery conduit.

18. The system of claim 17, further comprising a fluid delivery port formed in the ablation needle and coupled to the fluid delivery conduit.

19. The system of claim 17, further comprising a fluid delivery port formed in the catheter and coupled to the fluid delivery conduit.

20. The system of claim 17, wherein the fluid delivery device delivers an electrically conductive fluid containing an anesthetic agent.

21. The system of claim 17, wherein the ablation needle includes an electrically conductive needle, the ablation energy and the fluid both being delivered to the prostate via the needle.

22. The system of claim 17, further comprising a fluid delivery port formed in the catheter to deliver the fluid to a wall of a urethra of the patient.

23. The system of claim 17, wherein the fluid includes a steroid.

24. The system of claim 17, wherein the fluid includes a vaso-constrictor.